[go: up one dir, main page]

BRPI0821689A2 - Processo para a produção de derivados de piridina substituídos por heterociclo - Google Patents

Processo para a produção de derivados de piridina substituídos por heterociclo

Info

Publication number
BRPI0821689A2
BRPI0821689A2 BRPI0821689-4A BRPI0821689A BRPI0821689A2 BR PI0821689 A2 BRPI0821689 A2 BR PI0821689A2 BR PI0821689 A BRPI0821689 A BR PI0821689A BR PI0821689 A2 BRPI0821689 A2 BR PI0821689A2
Authority
BR
Brazil
Prior art keywords
production
pyridine derivatives
substituted pyridine
heterocycle substituted
heterocycle
Prior art date
Application number
BRPI0821689-4A
Other languages
English (en)
Inventor
Jun Niijima
Shinya Abe
Kazuhiro Yoshizawa
Yuki Kosaka
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of BRPI0821689A2 publication Critical patent/BRPI0821689A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • C07D213/6432-Phenoxypyridines; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0821689-4A 2007-12-26 2008-12-25 Processo para a produção de derivados de piridina substituídos por heterociclo BRPI0821689A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1679107P 2007-12-26 2007-12-26
PCT/JP2008/073545 WO2009081970A1 (ja) 2007-12-26 2008-12-25 ヘテロ環置換ピリジン誘導体の製造方法

Publications (1)

Publication Number Publication Date
BRPI0821689A2 true BRPI0821689A2 (pt) 2015-06-16

Family

ID=40801269

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821689-4A BRPI0821689A2 (pt) 2007-12-26 2008-12-25 Processo para a produção de derivados de piridina substituídos por heterociclo

Country Status (9)

Country Link
US (1) US8410277B2 (pt)
EP (1) EP2226320A4 (pt)
JP (1) JPWO2009081970A1 (pt)
CN (1) CN101910159B (pt)
BR (1) BRPI0821689A2 (pt)
CA (1) CA2709664A1 (pt)
IL (1) IL206391A0 (pt)
RU (1) RU2474581C2 (pt)
WO (1) WO2009081970A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1669348A4 (en) 2003-09-30 2009-03-11 Eisai R&D Man Co Ltd NEW ANTIPILIC AGENT CONTAINING A HETEROCYCLIC COMPOUND
WO2006106711A1 (ja) 2005-03-30 2006-10-12 Eisai R & D Management Co., Ltd. ピリジン誘導体を含有する抗真菌剤
TWI385169B (zh) 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
EP2065377B1 (en) 2006-09-21 2011-11-23 Eisai R&D Management Co., Ltd. Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
TW200841879A (en) 2007-04-27 2008-11-01 Eisai R&D Man Co Ltd Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
CN102702185A (zh) 2007-04-27 2012-10-03 卫材R&D管理有限公司 杂环取代吡啶衍生物的盐的结晶
US8513287B2 (en) 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
WO2010032874A1 (ja) * 2008-09-19 2010-03-25 住友化学株式会社 農業用組成物
US8188119B2 (en) 2008-10-24 2012-05-29 Eisai R&D Management Co., Ltd Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
WO2011051198A2 (de) 2009-10-30 2011-05-05 Bayer Cropscience Ag Pyridin-derivate als pflanzenschutzmittel
US9234112B2 (en) * 2013-06-05 2016-01-12 Korea Institute Of Machinery & Materials Metal precursor powder, method of manufacturing conductive metal layer or pattern, and device including the same
JP2016164126A (ja) * 2013-07-02 2016-09-08 日本曹達株式会社 アミノピリジン誘導体および農園芸用殺菌剤
CN109721640B (zh) * 2017-10-31 2025-01-14 鲁南制药集团股份有限公司 一种卡泊芬净中间体及其合成方法
IL275121B2 (en) 2017-12-07 2025-11-01 Amplyx Pharmaceuticals Inc Heterocycle substituted pyridine derivative antifungal agents
US11771688B2 (en) 2018-06-25 2023-10-03 Amplyx Pharmaceuticals, Inc. Pyridine derivatives substituted by heterocyclic ring and amino group
CA3121202A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3844227A1 (de) 1988-12-29 1990-07-05 Basf Ag 3(2h)-pyridazinonderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen
GB2276161A (en) 1993-03-17 1994-09-21 Glaxo Group Ltd Aniline and benzanilide derivatives
US5444050A (en) 1994-04-29 1995-08-22 Texas Biotechnology Corporation Binding of E-selectin or P-selectin to sialyl Lewisx or sialyl-Lewisa
FR2737721B1 (fr) * 1995-08-08 1997-09-05 Roussel Uclaf Nouveaux composes biphenyles, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicament et les compositions pharmaceutiques les contenant
ES2179490T3 (es) 1997-05-08 2003-01-16 Merck Sharp & Dohme Derivados de 1,2,4-triazolo(3,4-a)ftalazina sustituidos como ligandos de gaba alfa 5.
DE19917979A1 (de) 1999-04-21 2000-10-26 Clariant Gmbh Verfahren zur Herstellung von substituierten Phenyl-boronsäuren
NZ541266A (en) 2000-07-07 2006-11-30 Eisai Co Ltd DNA encoding proteins participating in fungal cell wall synthesis
PL365441A1 (en) 2001-04-05 2005-01-10 Torrent Pharmaceuticals Ltd. Heterocyclic compounds for aging-related and diabetic vascular complications
JP2005501822A (ja) 2001-06-27 2005-01-20 メルク フロスト カナダ アンド カンパニー 置換8−アリールキノリン系pde4阻害薬
JP2006502962A (ja) 2002-01-18 2006-01-26 ビーエーエスエフ アクチェンゲゼルシャフト ペルオキシドによる皮膚損傷を防止するための化粧用又は皮膚用製剤
WO2003104227A1 (de) 2002-01-20 2003-12-18 Bayer Healthcare Ag 2-heteroarylcarbonsäureamide
EP1549632A4 (en) 2002-05-28 2005-11-09 Dimensional Pharm Inc NEW THIOPHENAMIDINE, COMPOSITIONS AND METHOD FOR THE TREATMENT OF COMPLEMENTED DISEASES AND SUFFERING
US7153968B2 (en) * 2002-06-25 2006-12-26 Merck Frosst Canada, Ltd. 8-(biaryl)quinoline PDE4 inhibitors
KR20050115337A (ko) 2003-04-30 2005-12-07 디 인스티튜트스 포 파마슈티컬 디스커버리, 엘엘씨 단백질 티로신 포스파타제 ―1b의 억제제로서의 치환된아미노 카르복실산
WO2004100947A2 (en) 2003-05-06 2004-11-25 Smithkline Beecham Corporation Novel chemical compounds
EP1669348A4 (en) 2003-09-30 2009-03-11 Eisai R&D Man Co Ltd NEW ANTIPILIC AGENT CONTAINING A HETEROCYCLIC COMPOUND
JP2006248938A (ja) * 2005-03-09 2006-09-21 Kyowa Hakko Kogyo Co Ltd 含ホウ素キナゾリン誘導体
US7572808B2 (en) * 2005-06-17 2009-08-11 Bristol-Myers Squibb Company Triazolopyridine cannabinoid receptor 1 antagonists
CA2626767C (en) 2005-10-31 2012-01-17 Eisai R&D Management Co., Ltd. Heterocyclic substituted pyridine derivatives and antifungal agent containing same
TWI385169B (zh) 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
RU2380365C1 (ru) * 2005-10-31 2010-01-27 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Гетероциклические замещенные производные пиримидина и содержащий их противогрибковый агент
PE20121506A1 (es) 2006-07-14 2012-11-26 Amgen Inc Compuestos triazolopiridinas como inhibidores de c-met
US9259426B2 (en) * 2006-07-20 2016-02-16 Gilead Sciences, Inc. 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
EP2049520A4 (en) * 2006-08-07 2011-01-05 Ironwood Pharmaceuticals Inc indole compounds
WO2008023248A2 (en) 2006-08-24 2008-02-28 Wockhardt Research Centre Novel macrolides and ketolides having antimicrobial activity
MX2009008531A (es) 2007-02-16 2009-08-26 Amgen Inc Cetonas de heterociclilo que contienen nitrogeno y su uso como inhibidores de c-met.
CN102702185A (zh) 2007-04-27 2012-10-03 卫材R&D管理有限公司 杂环取代吡啶衍生物的盐的结晶
US8202873B2 (en) 2007-05-11 2012-06-19 Eli Lilly And Company 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor antagonists
US20090197880A1 (en) 2007-07-13 2009-08-06 Genelabs Technologies, Inc. Anti-viral compounds, compositions, and methods of use
UY31507A1 (es) * 2007-12-03 2009-07-17 Derivados de piridina activadores de guanilato ciclasa soluble

Also Published As

Publication number Publication date
JPWO2009081970A1 (ja) 2011-05-06
RU2010125902A (ru) 2012-02-10
WO2009081970A1 (ja) 2009-07-02
US8410277B2 (en) 2013-04-02
EP2226320A1 (en) 2010-09-08
RU2474581C2 (ru) 2013-02-10
CA2709664A1 (en) 2009-07-02
EP2226320A4 (en) 2012-07-11
IL206391A0 (en) 2010-12-30
US20110263845A1 (en) 2011-10-27
CN101910159B (zh) 2013-06-19
CN101910159A (zh) 2010-12-08

Similar Documents

Publication Publication Date Title
BRPI0821689A2 (pt) Processo para a produção de derivados de piridina substituídos por heterociclo
BRPI0920414A2 (pt) Processo para a produção de alfa-tocotrienal e seus derivados
BRPI0720070A2 (pt) Processo para produção de produtos de tecido
BR112012003615A2 (pt) processo para a produção de butadieno
BRPI0910916A2 (pt) Processo para a produção de um dianidroaçúcar
BRPI0816253A2 (pt) Processo para a produção de um produto de hidrocarboneto
BRPI0914788A2 (pt) Processo para a produção de um produto intermediário de etexilato de dabigatran
BRPI0810452A2 (pt) Processo para a produção de composições de betume
BRPI0719843A2 (pt) Método para a produção de bisbenzoxazóis
BRPI1012370A2 (pt) processo para a produção de olefinas
BRPI0923180A2 (pt) processo para a produção de produtos químicos
BRPI0816258A2 (pt) processo para a preparação de compostos úteis como inibidores de sglt
FI20075434L (fi) Prosessi haaroittuneiden hiilivetyjen valmistamiseksi
BRPI0922710A8 (pt) método para a produção de plaquetas
BR112012001078A2 (pt) Método para a produção de derivados de sulfóxido de 3-triazolila quirais
FI20075433L (fi) Prosessi haaroittuneiden hiilivetyjen valmistamiseksi
BRPI0812304A2 (pt) Processo para a produção de p4o6
BRPI0915441A2 (pt) processo para a produção de escória de espuma
BRPI1014812A2 (pt) Processo para a produção de alacoóis
BRPI0817747A2 (pt) Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico
BRPI0811644A2 (pt) Processo para a produção de pirazóis
BRPI0818541A2 (pt) Processo para a produção de um produto farmacêutico
BRPI0915572A2 (pt) processo para a fabricação de epicloroidrina
BRPI0813960A2 (pt) Processo para produção de biarilas
BRPI0809652A2 (pt) Processo melhorado para a síntese de solifenacina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.